Neuralink Exclusive: The First Monkey to Benefit from Groundbreaking Neuralink Advances Since 2021
Last week we had the opportunity to report from Neuralink, the cutting-edge neurotechnology company, who are excited to announce the arrival of Cornelius, a monkey who will be the first animal to undergo neural interface testing with the latest advancements to our brain-machine interface technology since 2021.
Cornelius will play a pivotal role in testing the newest updates to our system, pushing the boundaries of what’s possible in the future of neural interfaces.
Animal testing has been restarted to continue to develop highly sophisticated brain-machine interfaces (BMIs). This new phase of testing will take advantage of several important developments since the last animal demonstration in 2021.
The following objectives were shared with us to report on:
Higher resolution monitoring with precision for tracking neural activity and controlling devices.
Enhanced wireless data for more stable brain-to-device communication for smoother control.
Real-time BCI feedback creating algorithms for more intuitive brain-computer interaction.
Improved Implant Safety that enhances durability, minimizing risks for long-term use.
Final thing we learnt was the improved neural mapping – modem neurons monitored for deeper insights into brain function.
As part of the Neuralink team’s ongoing mission to bring life-changing advancements to those suffering from neurological diseases and disorders, Cornelius’ participation will be a key step toward the next phase of human trials. With the success of these new features, Neuralink is on track to make significant strides in areas like Parkinson’s disease treatment, paralysis rehabilitation, and beyond.
Neuralink remains committed to transparency and ethical practices in our animal testing, ensuring the highest standards of care and oversight. Cornelius will be closely monitored throughout the process to ensure his well-being and to optimize the performance of the technology, we will continue to report on the advancements with Cornelius and work against lobbying as after having the opportunity to deep dive into Cornelius’s role at Neurolink we are in full support of the decision to progress and advance, for not just humankind but animals as well.